About us
What we do
Our strategy
Market opportunity
Our team
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Financial calendar
Shareholder information
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Share price
INC GBp
About us
What we do
Our strategy
Market opportunity
Our team
Board of Directors
Senior Management
Advisors and Founders
Our History
Origins – Institute of Cancer Therapeutics (ICT) Bradford
Pipeline
Our products
For patients
Partnering
Our partnerships
Investors
Overview
Why invest?
IPO materials
Regulatory news
Results, Reports and Presentations
Research Notes
Email alerts
Share price and tools
Share price chart
Detailed share price
Financial calendar
Shareholder information
Shareholder Information
AGM
GM
Analyst coverage
Investor and Advisor contacts
AQSE Growth Market Rule 4.14
Corporate Governance
Corporate Governance Report
QCA Corporate Governance Principles
Company Contact Details
News & media
News
Press Coverage
Scientific Publications
Contact Us
Sustainability
Latest from Incanthera
Home
News & media
Latest from Incanthera
Latest from Incanthera
2024
2023
2022
Archive
June 12th, 2024
Incanthera chairman discusses new director, strategic fundraising and Aquis promotion
View full post
June 10th, 2024
Incanthera plc Appointment Senior Independent Director, Promotion to Apex
Download PDF
June 4th, 2024
AQSE Webinar Presentation 'Aquis Leading Lights: Meet the Company of the Year 2024 Nominees’
Download PDF
June 3rd, 2024
Skin + CELL First Production Order Doubled Again Institutional Investor-led Subscription and Sale Shares Totalling £4.1 million Posting of Circular of General Meeting
May 16th, 2024
Investor Presentation
Download the Presentation
April 23rd, 2024
Confirmation of Warrants Conclusion
Prev
1
2
3
Next